These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
294 related items for PubMed ID: 26991794
1. Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy. Donati M, Conforti A, Lenti MC, Capuano A, Bortolami O, Motola D, Moretti U, Vannacci A, Rafaniello C, Vaccheri A, Arzenton E, Bonaiuti R, Sportiello L, Leone R, DILI-IT Study Group. Br J Clin Pharmacol; 2016 Jul; 82(1):238-48. PubMed ID: 26991794 [Abstract] [Full Text] [Related]
2. Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care. Lacroix I, Lapeyre-Mestre M, Bagheri H, Pathak A, Montastruc JL, Club de Reflexion des cabinets de Groupe de Gastro-Enterologie (CREGG), General Practitioner Networks. Fundam Clin Pharmacol; 2004 Apr; 18(2):201-6. PubMed ID: 15066135 [Abstract] [Full Text] [Related]
3. Serious liver injury induced by Nimesulide: an international collaborative study. Bessone F, Hernandez N, Mendizabal M, Ridruejo E, Gualano G, Fassio E, Peralta M, Fainboim H, Anders M, Tanno H, Tanno F, Parana R, Medina-Caliz I, Robles-Diaz M, Alvarez-Alvarez I, Niu H, Stephens C, Colombato L, Arrese M, Reggiardo MV, Ono SK, Carrilho F, Lucena MI, Andrade RJ. Arch Toxicol; 2021 Apr; 95(4):1475-1487. PubMed ID: 33759010 [Abstract] [Full Text] [Related]
4. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area. Conforti A, Leone R, Moretti U, Mozzo F, Velo G. Drug Saf; 2001 Apr; 24(14):1081-90. PubMed ID: 11735663 [Abstract] [Full Text] [Related]
5. Nimesulide-induced hepatotoxicity: A systematic review and meta-analysis. Kwon J, Kim S, Yoo H, Lee E. PLoS One; 2019 Apr; 14(1):e0209264. PubMed ID: 30677025 [Abstract] [Full Text] [Related]
6. Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study. Gulmez SE, Unal US, Lassalle R, Chartier A, Grolleau A, Moore N. Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1174-1181. PubMed ID: 30112779 [Abstract] [Full Text] [Related]
10. Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy. Castellsague J, Pisa F, Rosolen V, Drigo D, Riera-Guardia N, Giangreco M, Clagnan E, Tosolini F, Zanier L, Barbone F, Perez-Gutthann S. Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):365-75. PubMed ID: 23229866 [Abstract] [Full Text] [Related]
11. Nimesulide: patients still exposed to a risk of severe hepatitis. Prescrire Int; 2011 May; 20(116):125-6. PubMed ID: 21648177 [Abstract] [Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? Bessone F. World J Gastroenterol; 2010 Dec 07; 16(45):5651-61. PubMed ID: 21128314 [Abstract] [Full Text] [Related]
13. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs. Traversa G, Bianchi C, Da Cas R, Abraha I, Menniti-Ippolito F, Venegoni M. BMJ; 2003 Jul 05; 327(7405):18-22. PubMed ID: 12842950 [Abstract] [Full Text] [Related]
14. Fatal hepatoxicity secondary to nimesulide. Merlani G, Fox M, Oehen HP, Cathomas G, Renner EL, Fattinger K, Schneemann M, Kullak-Ublick GA. Eur J Clin Pharmacol; 2001 Jul 05; 57(4):321-6. PubMed ID: 11549211 [Abstract] [Full Text] [Related]
15. Treatment of acute low back pain with the COX-2-selective anti-inflammatory drug nimesulide: results of a randomized, double-blind comparative trial versus ibuprofen. Pohjolainen T, Jekunen A, Autio L, Vuorela H. Spine (Phila Pa 1976); 2000 Jun 15; 25(12):1579-85. PubMed ID: 10851109 [Abstract] [Full Text] [Related]
16. Prescriptions of NSAIDs to patients undergoing third molar surgery : an observational, prospective, multicentre survey. Levrini L, Carraro M, Rizzo S, Salgarello S, Bertelli E, Pelliccioni GA, Garau V, Bandettini M, Caputi S, Lörincz A, Szûcs A. Clin Drug Investig; 2008 Jun 15; 28(10):657-68. PubMed ID: 18783304 [Abstract] [Full Text] [Related]
17. Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication. Licata A, Calvaruso V, Cappello M, Craxì A, Almasio PL. Dig Liver Dis; 2010 Feb 15; 42(2):143-8. PubMed ID: 19625223 [Abstract] [Full Text] [Related]
18. Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound. Dastis SN, Rahier J, Lerut J, Geubel AP. Eur J Gastroenterol Hepatol; 2007 Nov 15; 19(11):919-22. PubMed ID: 18049158 [Abstract] [Full Text] [Related]
19. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders. Asero R. Ann Allergy Asthma Immunol; 1999 Jun 15; 82(6):554-8. PubMed ID: 10400483 [Abstract] [Full Text] [Related]
20. Nimesulide-induced acute hepatitis. Sbeit W, Krivoy N, Shiller M, Farah R, Cohen HI, Struminger L, Reshef R. Ann Pharmacother; 2001 Sep 15; 35(9):1049-52. PubMed ID: 11573855 [Abstract] [Full Text] [Related] Page: [Next] [New Search]